“E.P.A. can no longer be confident that Enlist Duo will not cause risks of concern to nontarget organisms, including those listed as endangered, when used according to the approved label,” the agency said in its filing to the United States Court of Appeals for the Ninth Circuit in San Francisco.
Read more at the New York Times.